[Double-blind controlled study of the therapeutic effectiveness and tolerance of the guabenxan-bemetizid combination as compared with guanethidine-hydrochlorothiazide in arterial hypertension in the aged].
D000368:Aged; D001581:Benzothiadiazines / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000008:administration & dosage*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006145:Guanethidine / Q000008:administration & dosage* / Q000627:therapeutic use; D006146:Guanidines / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage* / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D049993:Sodium Chloride Symporter Inhibitors / Q000008:administration & dosage*; D013449:Sulfonamides
D001581:Benzothiadiazines; D004232:Diuretics; D004338:Drug Combinations; D006146:Guanidines; D049993:Sodium Chloride Symporter Inhibitors; D013449:Sulfonamides; D006852:Hydrochlorothiazide; C036328:tensigradyl; C036326:Esimil; C010100:dehydrosanol; C036327:guabenxan; D006145:Guanethidine
Studio controllato a doppia cecità sull'efficacia terapeutica e sulla tollerabilità dell'associazione guabenxano-bemetizide in confronto a guanetidina-idroclorotiazide nell'ipertensione arteriosa nell'anziano.